Last reviewed · How we verify

NCT04929275: RACO

Enhanced Recovery Programs and Small Bowel Obstruction

Completed NA Last updated 22 September 2023
What this trial tests

NA trial testing Enhanced recovery program in Small Bowel Obstruction in 50 participants. Completed in 3 December 2022.

Timeline
25 June 2021
Primary endpoint
3 November 2022
3 December 2022

Quick facts

Lead sponsorUniversity Hospital, Angers
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment50
Start date25 June 2021
Primary completion3 November 2022
Estimated completion3 December 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Angers

Who can join

18 and older, any sex, with Small Bowel Obstruction or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Small bowel obstruction surgery is frequent and would benefit from enhanced recovery programs. While some studies advocate for their feasibility, it has never been proved and prospective studies are required to confirm the feasibility of such program and the impact on postoperative outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Enhanced recovery programs following adhesive small bowel obstruction surgery are feasible and reduce the rate of postoperative ileus: a preliminary study.
    M L, G B, F F, M B, et al · · 2024 · PMID 38900305 · DOI 10.1007/s00423-024-03389-7

Verify or expand the search:

Other trials of Enhanced recovery program

Trials testing the same drug.

Other recruiting trials for Small Bowel Obstruction

Currently open trials in the same condition.

Other University Hospital, Angers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04929275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing